NCT00089258View on ClinicalTrials.gov

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

November 30, 2006

Conditions

Neuroblastoma

Interventions

BIOLOGICAL

beta-glucan

BIOLOGICAL

monoclonal antibody 3F8

BIOLOGICAL

sargramostim

DRUG

isotretinoin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00089258 - Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment | Biotech Hunter | Biotech Hunter